GPP
Great Point Partners’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-75,000
| Closed | -$7.31M | – | 45 |
|
|
2022
Q2 | $7.31M | Buy |
+75,000
| New | +$7.31M | 1.75% | 20 |
|
|
2018
Q2 | – | Sell |
-400,000
| Closed | -$33.2M | – | 33 |
|
|
2018
Q1 | $33.2M | Hold |
400,000
| – | – | 4.93% | 10 |
|
|
2017
Q4 | $31M | Sell |
400,000
-75,000
| -16% | -$5.82M | 5.3% | 6 |
|
|
2017
Q3 | $29.1M | Sell |
475,000
-125,000
| -21% | -$7.66M | 5.66% | 4 |
|
|
2017
Q2 | $27.6M | Buy |
600,000
+40,000
| +7% | +$1.84M | 4.94% | 8 |
|
|
2017
Q1 | $24.2M | Sell |
560,000
-190,000
| -25% | -$8.23M | 4.82% | 9 |
|
|
2016
Q4 | $29M | Buy |
750,000
+355,920
| +90% | +$13.8M | 5.96% | 6 |
|
|
2016
Q3 | $20M | Sell |
394,080
-75,920
| -16% | -$3.84M | 5.09% | 9 |
|
|
2016
Q2 | $21.4M | Buy |
470,000
+144,700
| +44% | +$6.58M | 6.12% | 7 |
|
|
2016
Q1 | $12.9M | Buy |
+325,300
| New | +$12.9M | 4.62% | 8 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 34 |
|
|
2014
Q4 | – | Sell |
-1,161,739
| Closed | -$18.2M | – | 32 |
|
|
2014
Q3 | $18.2M | Sell |
1,161,739
-350,364
| -23% | -$5.49M | 7.82% | 2 |
|
|
2014
Q2 | $22.4M | Buy |
1,512,103
+892,103
| +144% | +$13.2M | 9.98% | 1 |
|
|
2014
Q1 | $9.98M | Buy |
+620,000
| New | +$9.98M | 5.21% | 7 |
|